We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves Drug That Targets Key Genetic Driver of Cancer

News   Nov 27, 2018 | Original story from the Moffitt Cancer Center

 
FDA Approves Drug That Targets Key Genetic Driver of Cancer
 
 
Advertisement
 

RELATED ARTICLES

Protein Target for Future Antidepressants Identified

News

A recent study strongly suggests that the protein GPR56 is involved in the biology of depression, which could offer a novel target for new antidepressant drugs.

READ MORE

Exploring the Environmental Impacts of Cancer Drugs

News

Authors of a new study note that with hundreds of chemotherapeutic drugs currently in late-stage clinical development, it is essential to understand their toxicity in aquatic environments in order to inform future regulations.

READ MORE

Deep Cleaning on a Nanoscale

News

Scientists have developed a novel mechanical cleaning method for surfaces on the nanoscale. The technique successfully removes even the tiniest contaminants down to the atomic scale, achieving an unprecedented level of cleanliness.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE